Brief: Eurocine Vaccines: initiation of clinical study of nasal influenza vaccine candidate

Nidhogg Resources Holding AB (publ)

25/10/2016 08:55

Oct 25 (Reuters) - Eurocine Vaccines AB  EUCI.ST : 
    * Announced on Monday the start of a phase I/II clinical study of the quadrivalent influenza 
vaccine candidate Immunose FLU, a novel nose drop formulation based on the companys technology 
Endocine and inactivated split antigens 
    * The study is conducted during the present influenza season, 2016/2017, and the results are 
expected around mid-2017 
 
     
 Source text: http://bit.ly/2eAGpHT 
     
 Further company coverage:  EUCI.ST   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))